Contact Us
Drug Search Results
More Filters [+]

Shanchol

Alternative Names: Shanchol
Latest Update: 2024-05-01
Latest Update Note: PubMed Publication

Product Description

oral inactivated, or non-live cholera vaccine (Sourced from: https://www.cdc.gov/cholera/vaccines.html)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Dominican Republic | India | Malaysia | Philippines

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Shanchol

Countries in Clinic: Nepal

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Cholera

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
IVI OCV-S

P3

Completed

Cholera

2022-12-22

Recent News Events

Date

Type

Title

05/01/2024

PubMed

 Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial.

04/08/2024

PubMed

 Seroconversion and Kinetics of Vibriocidal Antibodies during the First 90 Days of Re-Vaccination with Oral Cholera Vaccine in an Endemic Population.

01/10/2024

PubMed

 Do Oral Cholera Vaccine and Water, Sanitation, and Hygiene Combine to Provide Greater Protection Against Cholera? Results From a Cluster-Randomized Trial of Oral Cholera Vaccine in Kolkata, India.

10/13/2023

News Article

 Cholera Vaccines Market Size, Share, Trends 2024-2032

10/11/2023

News Article

 Oral Cholera Vaccine Market Share, Projections and Future Opportunities Recorded For The Period Until 2023 to 2031

10/20/2022

News Article

 Global Anticholinergic Drugs Market Garnered around USD 6.2 Billion in 2021 and to Grow with a CAGR of ~6% during 2022-2031; Rising Number of Geriatric Population to Elevate Market Growth – Kenneth Research

08/19/2022

News Article

 Global Surgical Microscope Market to Garner around USD 3.5 Billion by 2031 and maintain a CAGR of ~11% during 2022-2031; Market to Grow on Account of Rising Incidence of Chronic Diseases among the Geriatric Populace–Kenneth Research

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions